<--> SHORE-C: Sussex Health Outcomes Research and Education in Cancer

Principal Investigator: Professor Dame Lesley Fallowfield

Lead Researchers: Professor Valerie Jenkins, Dr Susan Catt

Statistician: Dr Ivonne Solis-Trapala

Funded by: Boehringer Ingelheim GMBH

Progression Free Survival (PFS) is commonly used as an endpoint in clinical trials of novel cancer therapies. This study aims to find out what this means for patients. What they understand about and expect from these treatments and if the benefits from the treatment controlling the cancer make it worth any side effects they could or do experience.  

^ Top